Urinary Tract Infections Caused by Uropathogenic Escherichia coli: Mechanisms of Infection and Treatment Options

被引:98
作者
Zhou, Yang [1 ,2 ]
Zhou, Zuying [1 ,2 ]
Zheng, Lin [1 ,2 ]
Gong, Zipeng [1 ]
Li, Yueting [1 ]
Jin, Yang [1 ]
Huang, Yong [1 ,2 ]
Chi, Mingyan [1 ,2 ]
机构
[1] Guizhou Med Univ, State Key Lab Funct & Applicat Med Plants, Guizhou Prov Key Lab Pharmaceut, 4 Beijing Rd, Guiyang 550004, Peoples R China
[2] Guizhou Med Univ, Sch Pharmaceut Sci, 4 Beijing Rd, Guiyang 550004, Peoples R China
基金
中国国家自然科学基金;
关键词
urinary tract infections; uropathogenic Escherichia coli; alternative treatment options; INTRACELLULAR BACTERIAL COMMUNITIES; SPECTRUM BETA-LACTAMASES; SECRETED AUTOTRANSPORTER TOXIN; ENTERICA SEROTYPE TYPHIMURIUM; VITRO ANTIBACTERIAL ACTIVITY; SIDEROPHORE RECEPTOR IRON; CITRUS-RETICULATA BLANCO; VAGINAL MUCOSAL VACCINE; TROPAEOLI-MAJORIS HERBA; INNATE IMMUNE-RESPONSE;
D O I
10.3390/ijms241310537
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Urinary tract infections (UTIs) are common bacterial infections that represent a severe public health problem. They are often caused by Escherichia coli (E. coli), Klebsiella pneumoniae (K. pneumonia), Proteus mirabilis (P. mirabilis), Enterococcus faecalis (E. faecalis), and Staphylococcus saprophyticus (S. saprophyticus). Among these, uropathogenic E. coli (UPEC) are the most common causative agent in both uncomplicated and complicated UTIs. The adaptive evolution of UPEC has been observed in several ways, including changes in colonization, attachment, invasion, and intracellular replication to invade the urothelium and survive intracellularly. While antibiotic therapy has historically been very successful in controlling UTIs, high recurrence rates and increasing antimicrobial resistance among uropathogens threaten to greatly reduce the efficacy of these treatments. Furthermore, the gradual global emergence of multidrug-resistant UPEC has highlighted the need to further explore its pathogenesis and seek alternative therapeutic and preventative strategies. Therefore, a thorough understanding of the clinical status and pathogenesis of UTIs and the advantages and disadvantages of antibiotics as a conventional treatment option could spark a surge in the search for alternative treatment options, especially vaccines and medicinal plants. Such options targeting multiple pathogenic mechanisms of UPEC are expected to be a focus of UTI management in the future to help combat antibiotic resistance.
引用
收藏
页数:33
相关论文
共 283 条
[31]  
Chandra S, 2001, ASIAN J CHEM, V13, P1181
[32]   Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli [J].
Chang, U-Im ;
Kim, Hyung Wook ;
Wie, Seong-Heon .
KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (01) :145-155
[33]  
Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]
[34]   Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli:: A comparative genomics approach [J].
Chen, SL ;
Hung, CS ;
Xu, JA ;
Reigstad, CS ;
Magrini, V ;
Sabo, A ;
Blasiar, D ;
Bieri, T ;
Meyer, RR ;
Ozersky, P ;
Armstrong, JR ;
Fulton, RS ;
Latreille, JP ;
Spieth, J ;
Hooton, TM ;
Mardis, ER ;
Hultgren, SJ ;
Gordon, JI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (15) :5977-5982
[35]   Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding [J].
Chen, Swaine L. ;
Hung, Chia S. ;
Pinkner, Jerome S. ;
Walker, Jennifer N. ;
Cusumano, Corinne K. ;
Li, Zhaoli ;
Bouckaert, Julie ;
Gordon, Jeffrey I. ;
Hultgren, Scott J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (52) :22439-22444
[36]   Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections [J].
Chen, Yen-Hsu ;
Ko, Wen-Chien ;
Hsueh, Po-Ren .
EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (05) :587-596
[37]   Diagnosis and treatment of urinary tract infections across age groups [J].
Chu, Christine M. ;
Lowder, Jerry L. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 219 (01) :40-51
[38]   Who will develop new antibacterial agents? [J].
Cole, Stewart T. .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2014, 369 (1645)
[39]   Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E-coli during Chronic Infection [J].
Conover, Matt S. ;
Ruer, Segolene ;
Taganna, Joemar ;
Kalas, Vasilios ;
De Greve, Henri ;
Pinkner, Jerome S. ;
Dodson, Karen W. ;
Remaut, Han ;
Hultgren, Scott J. .
Cell Host & Microbe, 2016, 20 (04) :482-492
[40]  
Conrad A, 2013, Drug Res (Stuttg), V63, P65, DOI 10.1055/s-0032-1331754